Related Experiment Video
Updated: May 29, 2026

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
Human enterovirus infections in children at increased risk for type 1 diabetes: the Babydiet study
M-L Simonen-Tikka1, M Pflueger, P Klemola
1Intestinal Viruses Unit, National Institute for Health and Welfare, P.O. Box 30, FI-00271, Helsinki, Finland.
Insights
This study found no link between human enteroviruses (HEVs) in infants and the development of islet autoantibodies. HEV infections were not associated with diet, maternal diabetes, or symptoms in children.
Area of Science:
- Virology
- Immunology
- Pediatrics
Background:
- Type 1 diabetes risk is influenced by genetic and environmental factors.
- Early life infections are investigated for their role in autoimmune disease development.
- The Babydiet study examined gluten exposure and type 1 diabetes risk in high-risk children.
Purpose of the Study:
- To investigate human enteroviruses (HEVs) and other intestinal viruses in infants.
- To analyze the association between HEV infections and islet autoantibodies.
- To examine the relationship with dietary intervention, maternal diabetes, and clinical symptoms.
Main Methods:
- Analysis of 339 stool samples from 104 children during the first year of life.
- Detection of HEVs and other intestinal viruses using molecular methods.
- Correlation of viral findings with islet autoantibody status, diet, maternal history, and symptoms.
Main Results:
- HEV was detected in 23.1% of children, with HEV-A species being most common.
- No significant difference in HEV prevalence was observed between islet autoantibody-positive and -negative children.
- HEV prevalence showed no association with gluten exposure, maternal type 1 diabetes, or familial risk.
Conclusions:
- No correlation was found between early-life HEV presence and the development of islet autoantibodies.
- HEV infections in the first year of life were not associated with dietary interventions.
- No link was identified between HEV infections and maternal diabetes or clinical symptoms in this cohort.
Aims/Hypothesis:
The aim of this study was to examine human enteroviruses (HEVs) and other intestinal viruses derived from children who participated in the Babydiet intervention study and to analyse the findings according to the appearance of islet autoantibodies, dietary intervention, maternal type 1 diabetes and clinical symptoms.
Methods:
In the Babydiet study the influence of first gluten exposure (6 or 12 months) on the development of islet autoimmunity was investigated in 150 children with increased genetic and familial risk for type 1 diabetes. Blood and stool samples were collected at 3 monthly intervals until the age of 3 years and yearly thereafter. Infections and clinical symptoms were recorded daily for the first year. In the present study, 339 stool samples collected from 104 children during the first year of life were analysed for HEVs and a certain proportion of the samples were analysed for other intestinal viruses.
Results:
HEV was detected in 32 (9.4%) samples from 24 (23.1%) children. Altogether 13 serotypes were identified, with HEV-A species being the most common. Children with gastrointestinal symptoms had norovirus (3/11) and sapovirus (1/11) infections in addition to HEV (1/11). Of the 104 children, 22 developed islet autoantibodies. HEV infections were detected in 18% (4/22) and 24% (20/82) of islet-autoantibody-positive and -negative children, respectively (p = 0.5). The prevalence of HEV was similar in the gluten-exposed groups and in children from mothers with type 1 diabetes or from affected fathers and/or siblings (p = 1.0 and 0.6, respectively).
Conclusions/Interpretation:
No correlation was found between the presence of HEV in the first year of life and the development of islet autoantibodies. There was no association between HEV infections and dietary intervention, maternal diabetes or clinical symptoms.
Related Concept Videos
Type I Diabetes I: Introduction
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Type 2 and Gestational
Type I Diabetes II: Pathophysiology
Type I Diabetes III: Clinical Manifestations
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...

